Payment overview · 2025
General Payments
$135.59
3 reported records · 2 companies
Healthcare provider profile · identity verified
Craig Scott Turner, MD
Allopathic & Osteopathic Physicians|Family Medicine · MONROE, LA · NPI 1598738049
Verified facts
What the public records show
CMS Open Payments records show Craig Scott Turner, MD received $135.59 in general payments during 2025 across 3 reported records.
ACADIA Pharmaceuticals Inc accounted for 69.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ACADIA Pharmaceuticals Inc | Unresolved — no canonical attribution shown | $93.62 | 69.0% | 1 | 2025 |
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $41.97 | 30.9% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $135.59 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| NUPLAZID Normalized: nuplazid |
Drug | ACADIA Pharmaceuticals Inc | $93.62 | 1 | 2025 |
Source payment records
|
|||||
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $41.97 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 469 | 89 |
| Pantoprazole Sodium | Pantoprazole Sodium | 398 | 82 |
| Eliquis | Apixaban | 366 | 60 |
| Gabapentin | Gabapentin | 364 | 57 |
| Levothyroxine Sodium | Levothyroxine Sodium | 317 | 50 |
| Potassium Chloride | Potassium Chloride | 284 | 51 |
| Furosemide | Furosemide | 256 | 57 |
| Amlodipine Besylate | Amlodipine Besylate | 194 | 55 |
| Famotidine | Famotidine | 181 | 37 |
| Memantine Hcl | Memantine Hcl | 174 | 39 |
| Clopidogrel | Clopidogrel Bisulfate | 171 | 33 |
| Duloxetine Hcl | Duloxetine Hcl | 157 | 26 |
| Metoprolol Tartrate | Metoprolol Tartrate | 150 | 35 |
| Tamsulosin Hcl | Tamsulosin Hcl | 148 | 44 |
| Trazodone Hcl | Trazodone Hcl | 147 | 27 |
| Metoprolol Succinate | Metoprolol Succinate | 144 | 43 |
| Donepezil Hcl | Donepezil Hcl | 143 | 28 |
| Losartan Potassium | Losartan Potassium | 134 | 36 |
| Omeprazole | Omeprazole | 127 | 23 |
| Escitalopram Oxalate | Escitalopram Oxalate | 125 | 25 |
| Lisinopril | Lisinopril | 119 | 30 |
| Divalproex Sodium | Divalproex Sodium | 113 | 20 |
| Sertraline Hcl | Sertraline Hcl | 99 | 21 |
| Quetiapine Fumarate | Quetiapine Fumarate | 94 | 14 |
| Carvedilol | Carvedilol | 90 | 19 |
| Prednisone | Prednisone | 89 | 11 |
| Metformin Hcl | Metformin Hcl | 84 | 17 |
| Myrbetriq | Mirabegron | 84 | suppressed |
| Nifedipine Er | Nifedipine | 84 | 11 |
| Meloxicam | Meloxicam | 82 | 13 |
| Rivastigmine | Rivastigmine | 79 | 12 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 77 | 32 |
| Fluoxetine Hcl | Fluoxetine Hcl | 75 | 20 |
| Mirtazapine | Mirtazapine | 73 | 13 |
| Linzess | Linaclotide | 72 | 17 |
| Tizanidine Hcl | Tizanidine Hcl | 70 | 14 |
| Jardiance | Empagliflozin | 69 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 68 | 11 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 64 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 61 | 17 |
| Finasteride | Finasteride | 61 | 17 |
| Levetiracetam | Levetiracetam | 59 | 14 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 56 | 16 |
| Aripiprazole | Aripiprazole | 55 | 11 |
| Ezetimibe | Ezetimibe | 55 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 54 | 14 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 54 | suppressed |
| Spironolactone | Spironolactone | 53 | 11 |
| Allopurinol | Allopurinol | 51 | 12 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 51 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 50 | suppressed |
| Entresto | Sacubitril/Valsartan | 49 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 48 | suppressed |
| Januvia | Sitagliptin Phosphate | 44 | suppressed |
| Latanoprost | Latanoprost | 44 | 13 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 43 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 43 | suppressed |
| Ibuprofen | Ibuprofen | 43 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 41 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 40 | suppressed |
| Lovastatin | Lovastatin | 40 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 39 | 16 |
| Hydralazine Hcl | Hydralazine Hcl | 39 | 11 |
| Nebivolol Hcl | Nebivolol Hcl | 39 | suppressed |
| Rexulti | Brexpiprazole | 39 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 37 | 12 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 36 | 31 |
| Pravastatin Sodium | Pravastatin Sodium | 36 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 35 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 34 | 17 |
| Buspirone Hcl | Buspirone Hcl | 34 | 11 |
| Lamotrigine | Lamotrigine | 34 | suppressed |
| Fluconazole | Fluconazole | 33 | 21 |
| Brimonidine Tartrate | Brimonidine Tartrate | 32 | suppressed |
| Digoxin | Digoxin | 32 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 32 | 18 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 31 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 30 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 29 | 17 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 29 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 28 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 27 | 21 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 27 | suppressed |
| Pentoxifylline | Pentoxifylline | 27 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 27 | suppressed |
| Cilostazol | Cilostazol | 26 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 26 | suppressed |
| Torsemide | Torsemide | 26 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 24 | suppressed |
| Simvastatin | Simvastatin | 24 | suppressed |
| Amantadine | Amantadine Hcl | 23 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 23 | suppressed |
| Sulfasalazine | Sulfasalazine | 23 | suppressed |
| Chlorthalidone | Chlorthalidone | 22 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 22 | 22 |
| Hydrochlorothiazide | Hydrochlorothiazide | 22 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 22 | suppressed |
| Lactulose | Lactulose | 22 | suppressed |
| Levofloxacin | Levofloxacin | 22 | 17 |
| Sevelamer Carbonate | Sevelamer Carbonate | 22 | suppressed |
| Azithromycin | Azithromycin | 21 | 17 |
| Entacapone | Entacapone | 21 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 21 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 21 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 20 | suppressed |
| Methocarbamol | Methocarbamol | 20 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 20 | 14 |
| Ondansetron Odt | Ondansetron | 20 | 16 |
| Oxybutynin Chloride | Oxybutynin Chloride | 20 | suppressed |
| Roflumilast | Roflumilast | 20 | suppressed |
| Timolol Maleate | Timolol Maleate | 20 | suppressed |
| Colchicine | Colchicine | 19 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 19 | suppressed |
| Novolog Flexpen | Insulin Aspart | 19 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 19 | suppressed |
| Budesonide | Budesonide | 18 | suppressed |
| Glimepiride | Glimepiride | 18 | suppressed |
| Mirabegron Er | Mirabegron | 18 | suppressed |
| Mitigare | Colchicine | 17 | suppressed |
| Insulin Lispro | Insulin Lispro | 16 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 16 | suppressed |
| Baclofen | Baclofen | 15 | suppressed |
| Humulin R | Insulin Regular, Human | 15 | suppressed |
| Restasis | Cyclosporine | 15 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 14 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 14 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 14 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Bumetanide | Bumetanide | 13 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 13 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 13 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 13 | suppressed |
| Lacosamide | Lacosamide | 13 | suppressed |
| Nystatin | Nystatin | 13 | 11 |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 12 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 12 | suppressed |
| Creon | Lipase/Protease/Amylase | 12 | suppressed |
| Donepezil Hcl Odt | Donepezil Hcl | 12 | suppressed |
| Estradiol | Estradiol | 12 | suppressed |
| Glipizide | Glipizide | 12 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 12 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 12 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 12 | suppressed |
| Tradjenta | Linagliptin | 12 | suppressed |
| Celecoxib | Celecoxib | 11 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 11 | suppressed |
| Haloperidol | Haloperidol | 11 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 11 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 11 | suppressed |
| Risperidone | Risperidone | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $135.59 · 3 records | ACADIA Pharmaceuticals Inc | INGREZZA, NUPLAZID | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error